John Berry, MD
Sports Medicine · Hattiesburg, MSNPI 1356638977
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Stryker at 48.9% of the total. Reporting peaked in 2022 at $3,181 and has fallen 69.7% since, to $965 in 2025.
Across 42 payments — averaging $107.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Arthrex$1K
- ALON Medical Technology$628
- Zimmer Biomet$111
- Linkbio Corp$48
- Organogenesis Inc.$39
- plus $173 from 7 others
What the payments were for
- Speaking & faculty fees$1,00022%
- Travel & lodging$2,54457%
- Food & beverage$95721%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 18 | $2,200 |
| Arthrex | 4 | $1,303 |
| ALON Medical Technology | 8 | $628 |
| Zimmer Biomet | 1 | $111 |
| Linkbio Corp | 1 | $48 |
| Organogenesis Inc. | 2 | $39 |
| Boston Scientific | 1 | $38 |
| Vertex | 2 | $35 |
| Sanara Medtech Inc. | 1 | $33 |
| Smith+Nephew | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Catalyst Orthoscience | 1 | $17 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,501 in reported general payments places this provider in the 80th percentile of 33 sports medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 36 | $418 |
| Meloxicam | 139 | $338 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 70 | $256 |
| Celecoxib | 14 | $123 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $98 |
| Ondansetron Hcl | 29 | $75 |
| Tramadol Hcl | 35 | $72 |
| Gabapentin | 27 | $71 |
| Methocarbamol | 12 | $30 |
| Famotidine | 20 | $6 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Hattiesburg
- Jeremy WellsHattiesburg$2K
- Michael LandersHattiesburg$2K
- Lawrence LineHattiesburg$2K
- Christopher PentonHattiesburg$2K
- Nathan DarbyHattiesburg$762
- Jessica TullosHattiesburg$545
- Kevin ClementHattiesburg$226
- William RossHattiesburg$145
- Douglas RouseHattiesburg$34
- James Hurt IiiColumbus$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.